Showing results (591-600 of 750) with videos related to

Sort By:
Pageof 75
European Journal of Clinical Pharmacology|January 1, 1984
Chlorpropamide-alcohol flush: significance of body weight, sex and serum chlorpropamide levelL Groop, C J Eriksson, E Wåhlin-Boll, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1981
Effects of sulfonylurea on the secretion and disposition of insulin and C-peptideL O Almér, E Johansson, A Melander, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Influence of sulfonylureas on the secretion, disposal and effect of insulinL O Almér, E Johansson, A Melander, et al.
Diabetes Care|November 1, 1994
Comparison of excess costs of care and production losses because of morbidity in diabetic patientsJ Olsson, U Persson, C Tollin, et al.
Diabetes Care|February 1, 1994
Slow elimination of glyburide in NIDDM subjectsA Jönsson, T Rydberg, G Ekberg, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1988
Recombinant somatropin in treatment of growth hormone deficient children in Sweden and FinlandK Albertsson-Wikland, S Aronson, K O Nilsson, et al.
Diabetes, Obesity & Metabolism|March 21, 2002
The NEPI antidiabetes study (NANSY). 1: short-term dose-effect relations of glimepiride in subjects with impaired fasting glucoseU Lindblad, K Lindwall, A Sjöstrand, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Benzodiazepine prescribing patterns in a high-prescribing Scandinavian communityA Ekedahl, J Lidbeck, T Lithman, et al.
Annals of Internal Medicine|February 1, 1993
What is the benefit of increasing the sulfonylurea dose?S Stenman, A Melander, P H Groop, et al.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1984
Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists. A preliminary reportI Ingemarsson, H Liedholm, S Montan, et al.
Pageof 75